situ
physicochem
disinfect
high
risk
faecal
wast
effect
wide
use
sanit
manag
strategi
infect
prevent
control
systemat
test
perform
altern
physicochem
disinfect
method
systemat
compar
optim
must
base
reliabl
protocol
protocol
current
adequ
address
neutral
relat
issu
neutral
test
disinfect
specifi
condit
concentr
contact
time
ct
necessari
prevent
continu
disinfect
intend
contact
time
moreov
neutral
often
necessari
practic
larg
scale
prevent
advers
health
ecolog
impact
remain
disinfect
target
ct
achiev
studi
adequ
assess
extent
neutral
chemic
disinfect
intend
optim
onsit
disinfect
practic
wast
matric
pose
high
microbi
risk
henc
need
effect
reproduc
neutral
protocol
chemic
disinfect
trial
practic
furthermor
chemic
disinfect
use
healthcar
set
practic
methodolog
reliabl
conveni
measur
residu
disinfect
concentr
neutral
also
determin
optimum
concentr
neutral
neutral
compound
toxic
test
microorgan
necessari
optim
neutral
procedur
disinfect
experi
develop
infect
control
practic
use
accept
posit
control
microb
present
work
stepwis
bioassaybas
protocol
use
repres
faecal
indic
microb
describ
optim
chemic
disinfect
subsequ
disinfect
neutral
infecti
faecal
wast
matrix
exampl
describ
quaternari
ammonium
compound
benzalkonium
chlorid
recommend
chemic
neutral
high
strength
human
faecal
wast
matrix
oper
health
care
facil
emerg
eg
natur
disast
popul
displac
set
well
routin
condit
patient
excret
highli
infecti
bacteri
viral
pathogen
known
result
product
pathogenladen
human
excreta
insuffici
treat
infecti
wast
may
provid
pathway
transmiss
infecti
waterand
faecalborn
diseas
us
mani
highincom
countri
presum
adequ
treatment
facil
human
faecal
wast
potenti
infecti
bodili
fluid
healthcar
facil
discharg
directli
local
sewag
system
situ
pretreat
human
wast
sometim
encourag
certain
condit
introduct
high
risk
diseas
pathogen
popul
cholera
ashbolt
center
diseas
prevent
typhoid
fever
murphi
et
al
ebola
cdc
infecti
hepat
craun
et
al
sehulst
et
al
spina
et
al
world
health
organ
http
receiv
februari
receiv
revis
form
june
accept
juli
recommend
manag
wast
use
disinfect
option
et
al
unicef
howev
efficaci
exist
protocol
situ
inactiv
pathogen
human
faecal
wast
physicochem
disinfect
process
uncertain
especi
raw
faecal
matter
high
strength
wastewat
bibbi
et
al
schuit
et
al
tondera
et
al
tondera
et
al
chemic
agent
chlorin
bleach
tree
et
al
hydrat
lime
peracet
acid
allievi
et
al
kiti
alcohol
springthorp
et
al
tung
et
al
phenol
substanc
abad
et
al
mbithi
et
al
anion
deterg
gerba
kennedi
quaternari
ammonium
compound
benzalkonium
chlorid
bnz
tarbox
et
al
cetylpyridinium
chlorid
russel
main
disinfect
current
use
health
care
set
howev
suitabl
effect
compound
disinfect
complex
matric
high
organ
content
adequ
demonstr
use
paramet
develop
base
experiment
evid
abovement
outbreak
highli
contagi
diseas
associ
insuffici
treat
sewag
outbreak
indic
improv
better
document
method
need
ensur
effect
chemic
disinfect
protocol
infecti
faecal
wast
sewag
order
quantit
assess
disinfect
perform
candid
chemic
disinfect
identifi
effect
disinfect
condit
disinfect
dose
contact
time
ct
base
disinfect
kinet
disinfect
sampl
must
chemic
neutral
specifi
contact
time
sampl
analys
presenc
remain
microb
concern
chemic
neutral
disinfect
chemic
disinfect
experi
standard
practic
allow
reliabl
cultur
base
assay
faecal
indic
bacteria
eg
escherichia
coli
enterococcu
faecali
apha
c
bacteri
pathogen
surrog
bacteriophag
somat
coliphag
apha
gall
et
al
frna
phage
shahrampour
et
al
bacteroid
phage
ebdon
et
al
bacteriophag
casanova
weaver
casanova
weaver
viru
pathogen
surrog
complex
sewag
faecal
wast
matric
failur
achiev
adequ
chemic
neutral
disinfect
use
experi
result
flaw
disinfect
kinet
estim
base
ct
condit
inactiv
could
continu
experi
complet
due
variabl
unknown
remain
concentr
disinfect
biocid
byproduct
overestim
may
result
flaw
disinfect
protocol
produc
inaccur
disinfect
kinet
studi
investig
antimicrobi
properti
chemic
publish
recent
year
address
quantit
neutral
disinfect
agent
kingsley
et
al
peng
et
al
zanetti
et
al
chemic
disinfect
free
chlorin
concentr
reagent
biocid
byproduct
eg
chloramin
subsequ
neutral
compound
sodium
thiosulf
analys
chemic
simpl
reliabl
commerci
avail
method
howev
chemic
disinfect
simpl
standard
methodolog
measur
residu
concentr
attempt
neutral
residu
disinfect
may
present
low
concentr
activ
unless
chemic
agent
antimicrobi
effect
shown
absent
therefor
necessari
reliabl
assess
neutral
efficaci
disinfect
determin
minimum
requir
amount
neutral
assur
absenc
disinfect
end
specifi
contact
time
chemic
disinfect
whose
concentr
difficult
impract
measur
wast
matrix
microbi
bioassaybas
approach
determin
chemic
neutral
complex
wast
matrix
propos
present
work
addit
optim
perform
chemic
disinfect
inactiv
target
pathogen
base
disinfect
dose
contact
time
deliveri
method
specif
approach
method
need
optim
condit
chemic
neutral
activ
agent
eg
ad
sodium
thiosulf
chlorin
disinfect
treatment
conduct
disinfect
studi
develop
protocol
evalu
verifi
disinfect
perform
present
work
aim
provid
reliabl
simpl
method
determin
chemic
disinfect
complex
faecal
matrix
neutral
adequ
use
bioassay
procedur
document
cultur
target
microb
describ
protocol
aim
ensur
adequ
neutral
disinfect
achiev
interfer
subsequ
culturebas
microbi
analysi
process
sampl
use
bacteri
viral
indic
organ
spike
pasteur
autoclav
wastewat
prefer
use
natur
occur
organ
wast
matrix
sampl
two
reason
first
use
nonpathogen
indic
protect
health
safeti
laboratori
research
second
use
cultur
indic
organ
enabl
high
initi
titer
use
simplifi
process
quantifi
disinfect
perform
subsequ
chemic
neutral
disinfect
base
quantifi
microbi
level
ie
count
higher
therefor
statist
signific
ultim
accur
report
studi
evalu
impact
neutral
agent
surviv
faecal
indic
microorgan
neutral
compound
show
antimicrobi
properti
lyon
et
al
although
standard
protocol
exist
evalu
hospit
disinfect
includ
test
neutral
concentr
faecal
wast
organ
matric
encount
insitu
disinfect
applic
assess
surviv
recoveri
virus
bacteria
epa
establish
practic
simpl
adapt
protocol
reliabl
chemic
neutral
disinfect
use
insitu
wast
disinfect
applic
main
object
work
present
work
bioassay
approach
util
bacteria
bacteriophag
appli
specif
case
quaternari
ammonium
disinfect
benzalkonium
chlorid
bnz
exampl
disinfect
insitu
treatment
health
care
associ
faecal
wast
howev
present
method
design
appli
chemic
disinfect
process
matric
previou
research
compar
efficaci
differ
chemic
capabl
neutral
quaternari
ammonium
compound
bnz
low
concentr
tween
langsrud
sundheim
aqueou
solut
gl
sodium
dodecylsulph
gl
polysorb
gl
lecithin
raggi
et
al
aqueou
solut
tween
lecithin
sodium
thiosulf
proteos
pepton
trypton
sickbertbennett
et
al
use
three
studi
cite
astm
e
valid
use
mixtur
tween
lecithin
astm
junka
et
al
use
mixtur
tween
soybean
lecithin
sodium
thiosulf
neutral
avail
bnz
disinfect
literatur
provid
precis
level
ratio
tween
lecithin
andor
neutral
chemic
studi
includ
detail
inform
ratio
neutral
mixtur
disinfect
agent
investig
efficaci
neutral
complex
matric
simul
faecal
wast
sampl
knowledg
present
work
first
attempt
design
standard
approach
measur
residu
bnz
use
microbi
bioassay
attempt
chemic
neutral
furthermor
bioassay
describ
repres
improv
compar
abovement
studi
present
advantag
address
issu
potenti
microbi
inactiv
neutral
efficaci
neutral
procedur
evalu
bioassay
two
strain
e
coli
still
commonli
use
faecal
indic
bacteria
high
low
incom
set
worldwid
bacteriophag
bacteriophag
infect
pseudomona
syringa
adcock
et
al
apha
employ
recent
potenti
surrog
high
risk
epidem
envelop
human
virus
avian
influenza
ebola
casanova
weaver
bacteriophag
consid
possibl
surrog
envelop
virus
aim
evalu
disinfect
residu
brief
explan
rational
final
choic
recent
year
shown
emerg
number
outbreak
associ
envelop
virus
ebola
viru
baiz
et
al
coronavirus
sar
hsieh
et
al
virus
associ
middl
eastern
respiratori
syndrom
mer
haagman
et
al
high
persist
toward
disinfect
method
coupl
low
infecti
dose
high
number
infecti
virus
excret
human
wast
lead
requir
biosafeti
facil
level
safe
handl
therefor
envelop
bacteriophag
vidav
et
al
current
discuss
suitabl
surrog
due
sever
advantag
characterist
nonhuman
pathogen
natur
p
syringa
bacteri
host
wei
et
al
allow
handl
bio
safeti
level
equival
minim
contain
gallandat
lantagn
addit
easili
cultiv
analys
rapidli
use
establish
cultur
techniqu
plaqu
assay
iscompar
envelop
bacteriophag
famili
cystovirida
mindich
et
al
well
describ
character
literatur
laurinaviciu
et
al
still
recent
studi
de
carvalho
et
al
indic
even
though
show
behaviour
similar
envelop
enter
virus
highest
public
health
relev
certain
limit
regard
persist
toward
temperatur
decay
rate
deioniz
natur
water
exist
base
experi
previou
studi
municip
sewag
consid
repres
highli
challeng
faecal
wast
matric
complex
sewag
composit
excret
patient
healthcar
set
central
wast
water
treatment
absent
conduct
limit
extent
therefor
highli
microbi
contamin
highrisk
human
faecal
wast
hrhw
matrix
creat
mix
part
hospit
sewag
unc
hospit
chapel
hill
nc
usa
part
donat
raw
human
faec
volvol
matrix
use
worst
case
sampl
disinfect
bnz
faecal
sampl
use
collect
sealabl
collect
contain
volunt
work
unc
environment
virolog
laboratori
either
process
immedi
store
longer
four
week
ensur
compar
hospit
sewag
collect
three
sampl
site
manhol
unc
hospit
equal
volum
one
sampl
site
combin
form
composit
sampl
faecal
hospit
sampl
mix
vigor
ratio
upon
arriv
laboratori
result
matrix
store
repres
sampl
worst
case
faecal
wast
matrix
analys
environment
protect
agenc
certifi
commerci
laboratori
microbac
laboratori
marietta
oh
paramet
analys
includ
biochem
oxygen
demand
bod
total
suspend
solid
tss
total
organ
carbon
toc
chemic
oxygen
demand
cod
ammonia
content
ph
measur
unc
environment
virolog
lab
use
electron
glass
ph
electrod
thermo
fisher
scientif
waltham
usa
bacteriophag
stock
kindli
provid
dr
lisa
casanova
georgia
state
univers
propag
accord
instruct
provid
collabor
research
group
casanova
waka
util
sloppi
agar
method
avoid
contamin
loss
viral
infect
phage
aliquot
pb
dmso
avoid
capsid
damag
due
format
ice
crystal
store
longer
month
min
experi
semiquantit
approach
accord
din
en
iso
iso
quantif
somat
coliphag
chosen
evalu
loss
viru
infect
brief
sampl
dilut
steril
pb
combin
ml
logphas
p
syringa
ml
molten
semi
solid
tryptic
soy
agar
tsa
mgcl
mix
well
pour
tsa
plate
incub
h
viral
plaqu
confluent
bacteri
lawn
count
plaqu
form
unit
pfu
per
ml
adjust
dilut
factor
bacteri
indic
quantifi
use
spreadplat
method
standard
tsa
plate
accord
din
en
iso
iso
apha
briefli
aliquot
pipet
onto
tsa
plate
spread
use
steril
spreader
aerob
incub
h
experiment
methodolog
studi
detail
fig
control
aqueou
sampl
contain
faecal
wast
sewag
fig
high
strength
faecal
wast
sampl
inform
found
appendix
avail
literatur
provid
specif
indic
regard
optim
ratio
avail
neutral
compon
preliminari
experi
util
equal
proport
avail
neutral
agent
conduct
ratio
chosen
assum
neutral
compon
equal
import
neutral
disinfect
agent
ratio
two
neutral
agent
adjust
necessari
later
stage
process
optim
goal
reduc
proport
compon
caus
problem
creat
unnecessari
foam
expens
studi
mixtur
candid
neutral
agent
tween
lecithin
use
initi
main
paramet
consid
preliminari
trial
ratio
neutral
mix
disinfect
neutral
regardless
proport
neutral
agent
eg
tween
lecithin
exampl
neutral
mixtur
made
exampl
lecithin
tween
bnz
disinfect
would
result
ratio
neutral
cocktail
disinfect
agent
initi
experi
proport
tween
lecithin
vari
focu
defin
disinfect
neutral
mix
ratio
call
ratio
sever
preliminari
experi
mixtur
tween
lecithin
defin
proport
two
neutral
compon
simpli
proport
result
foam
due
surfact
ie
emulsifi
properti
tween
therefor
decid
anoth
aim
studi
increment
reduc
quantiti
proport
tween
neutral
mix
cocktail
much
possibl
best
mixtur
allow
use
lowest
possibl
proport
tween
compar
lecithin
still
neutral
mix
effect
tween
lecithin
proport
describ
next
section
research
hypothesi
test
studi
spread
plate
assay
high
concentr
indic
microb
spike
test
sampl
could
use
bioassay
indirectli
assess
abil
tween
lecithin
neutral
mix
complet
neutral
disinfect
first
set
experi
differ
ratio
bnz
neutral
use
effect
bacteri
growth
viral
infect
assess
semiquantit
sort
categori
base
number
coloni
plaqu
mm
tsa
plate
use
confluent
lawn
host
bacteria
case
shown
tabl
rel
extent
neutral
readili
discern
visual
comparison
neutral
sampl
contain
chemic
disinfect
bnz
posit
control
sampl
contain
disinfect
also
neutral
microbi
growth
viral
infect
precis
quantifi
especi
high
number
coloni
plaqu
observ
semiquantit
classif
assay
plate
base
observ
extent
microbi
growthinhibit
neutral
control
plate
neutral
disinfect
plate
shown
tabl
assess
perform
compar
plate
repres
neutral
sampl
equival
control
bacteri
viral
plate
replic
aliquot
bacteri
viral
suspens
titer
inocul
type
agar
disinfect
ad
therefor
give
optim
bacteri
viral
growth
incub
plate
compar
result
score
use
oper
definit
describ
tabl
obtain
confirmatori
result
two
set
trial
use
bacteri
indic
viral
indic
introduc
confirm
result
indic
viru
chosen
due
structur
behaviour
similar
high
risk
envelop
virus
ebolaviru
avian
influenza
viru
prepar
describ
casanova
weaver
neutral
ad
disinfect
viru
stock
spike
mixtur
sampl
plate
use
doubl
agar
layer
dal
method
modifi
us
epa
method
epa
neg
control
test
perform
explain
bacteri
indic
initi
neutral
mixtur
soylecithin
tween
vv
neutral
bnz
first
test
phosphat
buffer
solut
pb
fig
either
ml
pure
bnz
ad
ml
plastic
reaction
tube
pb
ad
tube
nine
ml
total
volum
reach
final
concentr
bnz
reach
respect
neg
control
ml
ecoli
f
amp
host
bnz
neutral
use
ensur
test
microb
still
viabl
three
differ
concentr
neutral
bnz
ml
ecoli
f
amp
host
spike
test
effect
amount
neutral
bacteri
growth
third
control
contain
bnz
ecoli
f
amp
host
test
effect
disinfect
bacteri
growth
approach
condit
use
tube
contain
test
viru
test
neutral
solut
aim
achiev
final
neutral
concentr
test
reactor
spike
mixtur
mixtur
vortex
left
static
min
make
sure
neutral
suffici
time
combin
disinfect
chemic
reaction
neutral
occur
neutral
reaction
complet
ml
e
coli
host
exponenti
growth
phase
ad
mixtur
vortex
immedi
spread
tsa
plate
plate
incub
h
bacteri
growth
plaqu
format
assess
numer
scale
explain
shown
diagram
bacteri
growth
plaqu
format
satisfactori
experi
repeat
first
decreas
ratio
neutral
solut
disinfect
minimum
requir
threshold
determin
experi
repeat
increment
decreas
concentr
tween
neutral
solut
without
alter
ratio
disinfect
neutral
solut
threshold
valu
give
optimum
neutral
anoth
aim
studi
defin
gener
procedur
follow
futur
studi
increment
reduct
made
amount
given
neutral
compon
may
necessari
neutral
process
also
caus
undesir
effect
neutral
compon
elimin
use
minim
minimum
tween
threshold
identifi
lowest
percentag
still
give
success
neutral
therefor
bacteri
growth
entir
experi
repeat
viral
indic
use
ratio
disinfect
neutral
mix
tween
lecithin
proport
experi
success
next
experiment
phase
use
target
faecal
wast
matrix
done
experiment
procedur
neutral
trial
use
human
faecal
wast
matrix
confirmatori
neutral
trial
faecal
wast
matrix
analog
experi
perform
pb
flow
diagram
method
condit
present
fig
detail
stepbystep
experiment
procedur
provid
supplementari
materi
section
initi
trial
pb
use
vv
mixtur
tween
lecithin
shown
tabl
trial
pb
bacteria
growth
becam
higher
higher
neutral
concentr
ie
neutral
concentr
increas
gener
bacteri
growth
parallel
trend
expect
bacteri
growth
observ
lower
higher
concentr
bnz
start
neutral
mixtur
neutral
mixtur
ad
bnz
bacteri
growth
seen
ratio
neutral
mix
disinfect
increment
increas
ratio
optim
ratio
higher
ad
bnz
bacteri
growth
seen
ratio
neutral
mix
disinfect
increment
increas
higher
neutral
concentr
never
reach
optim
growth
would
requir
ratio
neutral
protocol
optim
pb
trial
employ
thorough
mix
regim
tween
lecithin
tween
lecithin
lower
concentr
bnz
lower
concentr
neutral
mixtur
use
accord
result
tabl
increas
bacteri
growth
neutral
final
concentr
increas
ie
neutral
concentr
increas
expect
gener
bacteri
growth
parallel
trend
origin
expect
higher
amount
bnz
higher
concentr
neutral
mixtur
need
obtain
bacteri
growth
optimum
bacteria
growth
observ
follow
condit
bnz
neutral
concentr
ad
bnz
bacteri
growth
seen
ratio
neutral
mix
disinfect
becam
optim
ratio
higher
ad
bnz
modest
bacteri
growth
seen
ratio
neutral
mix
disinfect
highest
disinfect
concentr
bnz
possibl
go
beyond
neutral
mix
disinfect
ratio
alreadi
correspond
neutral
concentr
analysi
repres
sampl
worst
case
faecal
wast
matrix
gave
follow
result
ph
bod
mgl
cod
mgl
tss
mgl
ammonia
mgl
experi
conduct
faecal
wast
sampl
use
disinfect
experi
high
load
organ
matter
faecal
sampl
requir
higher
ratio
neutral
expect
shown
tabl
expect
concentr
neutral
mixtur
need
achiev
bacteri
growth
higher
amount
ad
disinfect
higher
faecal
wast
experi
perform
volvol
tween
vs
lecithin
proport
neutral
minim
amount
tween
reduc
sampl
foam
optimum
bacteria
growth
observ
follow
condit
bnz
neutral
concentr
ad
bnz
ratio
neutral
mix
disinfect
bacteri
growth
therefor
neutral
optim
ad
bnz
medium
good
bacteri
growth
seen
ratio
neutral
mix
disinfect
increment
increas
ad
bnz
minim
bacteri
growth
seen
ratio
neutral
mix
disinfect
highest
disinfect
concentr
bnz
possibl
go
beyond
neutral
mix
disinfect
ratio
alreadi
correspond
neutral
concentr
matrix
effect
neutral
protocol
evalu
use
viral
indic
result
experi
bacteri
indic
substanti
confirm
summar
tabl
volvol
tween
vs
lecithin
proport
use
gave
neutral
result
compar
superior
result
equival
volvol
condit
less
sampl
foam
ad
bnz
medium
level
plaqu
form
unit
seen
ratio
neutral
mix
disinfect
ad
bnz
medium
level
plaqu
form
unit
seen
ratio
neutral
mix
disinfect
ad
bnz
medium
good
plaqu
form
unit
level
seen
ratio
neutral
mix
disinfect
highest
disinfect
concentr
bnz
possibl
go
beyond
neutral
mix
disinfect
ratio
correspond
neutral
concentr
matrix
anoth
set
experi
pb
done
even
lower
concentr
tween
test
possibl
reduc
sampl
foam
end
neutral
process
effect
neutral
mixtur
loss
plaqueform
unit
also
test
harm
effect
higher
amount
neutral
mixtur
trial
use
less
tween
neutral
mixtur
proport
gave
low
foam
level
desir
result
unfortun
inconsist
neutral
result
see
exampl
viru
infect
ad
bnz
ratio
neutral
mix
disinfect
tabl
minimum
amount
tween
consid
best
compromis
provid
effect
replic
neutral
result
also
maintain
foam
accept
level
limit
trial
perform
use
tween
lecithin
proport
therefor
result
relat
trial
report
tabl
neutral
disinfect
ratio
use
volvol
tween
lecithin
proport
found
effect
condit
optim
neutral
bnz
tabl
data
initi
experi
chemic
neutral
bnz
pb
mixtur
tween
lecithin
use
differ
neutral
concentr
indic
observ
bacteri
growth
indic
differ
level
bacteri
growth
see
tabl
neutralizerdisinfect
ratio
report
combin
bnz
bacteri
growth
see
scale
tabl
e
sozzi
et
al
intern
journal
hygien
environment
health
minim
foam
shown
tabl
ad
bnz
good
level
plaqu
form
unit
seen
ratio
neutral
mix
disinfect
situ
chemic
disinfect
human
faecal
wast
healthcar
facil
show
promis
effect
barrier
pathogen
thu
contribut
adequ
infect
prevent
control
bartram
cairncross
freeman
et
al
singer
de
castro
sozzi
et
al
recent
studi
best
practic
perform
rapid
situ
chemic
disinfect
human
sewag
faecal
wast
healthcar
set
util
differ
establish
routin
use
disinfect
chlorin
bleach
hydrat
lime
alcohol
phenolbas
substanc
anion
deterg
quaternari
ammonium
compound
bnz
cetylpyridinium
chlorid
differ
use
condit
exposur
time
disinfect
concentr
vari
wast
matric
main
aim
studi
defin
tabl
efficaci
chemic
neutral
faecal
wast
sampl
disinfect
bnz
base
e
coli
growth
differ
neutralizerdisinfect
ratio
differ
neutral
concentr
trial
perform
use
mixtur
tween
lecithin
indic
bacteri
growth
indic
differ
level
bacteri
growth
see
tabl
neutralizerdisinfect
ratio
report
combin
ratio
neutral
mix
disinfect
neutral
proport
two
neutral
agent
defin
materi
method
section
ratio
defin
volvol
bnz
bacteri
growth
see
scale
tabl
three
day
incub
tabl
efficaci
chemic
neutral
faecal
sampl
base
growth
surrog
virus
bacteriophag
infect
p
syringa
differ
bnz
concentr
neutral
concentr
neutralizerdisinfect
ratio
trial
perform
use
mixtur
tween
lecithin
indic
viral
growth
indic
differ
level
viral
growth
see
tabl
neutralizerdisinfect
ratio
report
combin
ratio
neutral
mix
disinfect
neutral
proport
two
neutral
agent
defin
materi
method
section
ratio
defin
volvol
adapt
effect
scalabl
protocol
chemic
neutral
candid
chemic
disinfect
test
optim
perform
efficaci
high
strength
human
faecal
wast
matric
use
microbi
bioassay
system
absenc
reliabl
avail
method
analys
disinfect
residu
attempt
chemic
neutral
see
tabl
initi
experi
perform
pb
document
use
condit
success
neutral
disinfect
bnz
use
bacteri
bioassay
growth
bioassay
bacterium
e
coli
confirm
effect
neutral
could
quantifi
visual
use
vv
vv
neutral
mixtur
volum
concentr
low
high
concentr
bnz
result
consist
previou
studi
differ
wast
matric
context
health
care
facil
gainor
et
al
msellati
et
al
tarbox
et
al
subsequ
experi
show
greater
neutral
concentr
bacteri
viral
growth
increas
bacteria
growth
format
plaqu
lawn
host
bacteria
case
bacteriophag
benchmark
efficaci
experiment
setup
absenc
activ
disinfect
control
expect
result
neg
control
includ
either
disinfect
neutral
neutral
without
ad
disinfect
confirm
bacteri
growth
condit
show
bioassay
perform
expect
absenc
disinfect
neutral
expect
neutral
advers
effect
bacteri
viral
growth
disinfect
posit
control
contain
bnz
plu
indic
bacteria
virus
show
microbi
growth
expect
chemic
neutral
bnz
success
systemat
approach
neutral
use
use
vv
neutral
mixtur
result
bacteri
growth
compar
use
vv
mixtur
allow
better
mix
without
foam
vv
vv
neutralizermix
lower
tween
percentag
led
inconclus
result
therefor
minimum
concentr
tween
recommend
consid
optim
neutral
disinfect
agent
bnz
experiment
faecal
wast
matrix
consist
mixtur
human
faec
raw
hospit
sewag
worst
case
human
wast
sampl
effect
neutral
perform
achiev
progress
increas
concentr
neutral
ad
document
increas
bacteri
growth
experiment
condit
test
use
indic
viru
faecal
wast
matrix
result
indic
vv
mixtur
tween
soy
lecithin
success
neutral
bnz
allow
envelop
bacteriophag
pathogen
indic
viru
infect
p
syringa
host
chemic
neutral
faecal
wast
sampl
pb
document
higher
amount
neutral
mixtur
advers
impact
growth
either
bacteria
infect
bacteriophag
use
bioassay
microb
knowledg
present
work
constitut
first
studi
success
establish
reproduc
test
practic
flexibl
easili
scalabl
methodolog
bioassaybas
stepwis
protocol
evalu
use
insitu
chemic
disinfect
studi
wast
matric
bnz
disinfect
use
studi
result
suggest
broad
adapt
chemic
disinfect
measur
chemic
concentr
may
difficult
descript
evalu
disinfect
test
protocol
condit
present
sever
standard
public
work
block
russel
howev
public
adequ
address
current
situat
need
assess
efficaci
disinfect
steril
assay
broad
varieti
pathogen
microorgan
high
strength
complex
faecal
wast
matric
high
concentr
oxidiz
constitu
high
risk
persist
emerg
pathogen
envelop
virus
protocol
attempt
serv
gener
methodolog
appli
chemic
neutral
disinfect
chemic
studi
investig
disinfect
highli
oxidiz
human
faecal
wast
liquid
sampl
mani
context
health
care
emerg
respons
set
knowledg
approach
method
present
first
standard
protocol
address
chemic
disinfect
neutral
faecal
wast
matric
focu
research
call
worst
case
matric
protocol
current
avail
disinfect
test
healthcar
biocid
adequ
repres
kind
human
wast
sampl
condit
address
studi
highli
adapt
protocol
enabl
accur
assess
neutral
disinfect
given
disinfect
concentr
contact
time
adapt
natur
protocol
could
use
determin
optim
chemic
neutral
procedur
disinfect
appli
given
faecal
wast
highli
organ
liquid
wast
matrix
disinfect
public
health
protect
manasfi
et
al
schaefer
et
al
ufermann
et
al
prioriti
accur
assess
efficaci
chemic
neutral
protocol
forchem
disinfect
studi
control
condit
differ
faecal
wast
treat
differ
disinfect
system
describ
may
broader
applic
tabl
efficaci
chemic
neutral
pb
sampl
base
infect
surrog
bacteriophag
capabl
infect
p
syringa
score
differ
bnz
concentr
neutral
concentr
neutralizerdisinfect
ratio
tween
lecithin
proport
trial
perform
use
mixtur
tween
lecithin
indic
plaqu
format
indic
differ
level
plaqu
format
see
tabl
ratio
neutral
mix
disinfect
neutral
proport
two
neutral
agent
defin
materi
method
section
ratio
defin
volvol
bnz
condit
hygien
manag
faecal
sludg
wastewat
must
achiev
rapidli
rel
low
cost
low
high
resourc
set
author
declar
conflict
interest
support
nation
scienc
foundat
opinion
find
conclus
recommend
express
materi
author
necessarili
reflect
view
nation
scienc
foundat
combin
neg
control
trial
condit
possibl
type
studi
tabl
neg
control
trial
possibl
type
studi
studi
neg
control
systemat
perform
neg
control
perform
prove
bnz
effect
prevent
bacteri
viral
growth
expect
chemic
disinfect
neg
control
see
tabl
use
ensur
test
microb
perform
expect
rel
high
amount
neutral
mixtur
use
compromis
result
affect
surviv
spike
microbi
strain
includ
condit
bnz
neutral
condit
one
sampl
bnz
neutral
expect
spike
bacteria
abl
grow
first
set
neg
control
plate
use
second
neg
control
neutral
normal
bacteri
viral
growth
seen
ensur
harm
effect
neutral
bacteri
viral
stock
shown
fig
concentr
bnz
test
rational
behind
choic
sinc
bnz
concentr
typic
use
microbiolog
laboratori
disinfect
due
highli
organ
natur
conserv
faecal
wast
matrix
use
experi
decid
start
experi
typic
bnz
concentr
increas
concentr
factor
maximum
higher
concentr
bnz
could
realist
appli
hospit
set
elsewher
bnz
may
potenti
present
risk
mutagen
effect
development
toxic
use
improperli
high
concentr
moreov
use
concentr
even
nondilut
bnz
may
also
make
hazard
risk
skin
contact
ingest
eye
contact
inhal
sciencelab
use
agar
medium
spread
plate
bioassay
assess
abil
neutral
disinfect
describ
fig
high
e
coli
titer
chosen
indic
bacterium
spike
disinfect
sampl
attempt
chemic
neutral
agar
medium
plate
use
test
differ
chemic
neutral
altern
effect
allow
bacteri
growth
plate
one
effect
allow
suffici
bacteri
growth
plate
e
coli
strain
use
high
titer
stock
e
coli
f
amp
propag
within
lab
chemic
disinfect
neutral
studi
perform
show
fig
test
optim
neutral
mixtur
tween
lecithin
vv
neutral
bnz
faecal
wast
matrix
follow
step
taken
similarli
trial
perform
pb
fig
prepar
neutral
sampl
ml
faecal
sampl
pure
bnz
ad
two
plastic
tube
mixtur
vortex
neutral
mixtur
ad
sampl
accordingli
mix
min
allow
settl
min
ml
e
coli
f
amp
spike
sampl
vortex
allow
settl
min
mixtur
briefli
vortex
immedi
spread
plate
tsa
tsa
plate
incub
h
check
presenc
bacteri
viral
growth
preliminari
set
experi
neutral
concentr
narrow
chemic
neutral
bioassay
trial
done
differ
set
experi
yield
differ
result
set
initi
experi
pb
gave
success
result
base
bacteri
growth
increas
level
higher
concentr
neutral
ad
howev
second
third
set
trial
show
sign
bacteri
growth
chemic
neutral
lead
systemat
investig
differ
variabl
condit
neutral
process
variabl
condit
includ
differ
sampl
mix
regim
longer
versu
shorter
shake
time
differ
shake
intens
manual
mix
vs
mechan
vortex
mix
use
streptomycin
ampicillin
antibiot
indic
bacterium
e
coli
f
amp
suscept
potenti
inhibitori
growth
contamin
bacteri
agent
growth
phase
physiolog
condit
e
coli
bioassay
bacteria
use
spike
test
sampl
either
exponenti
growth
phase
plateau
growth
phase
effect
sampl
incub
temperatur
chemic
neutral
experi
separ
investig
effect
variabl
condit
e
coli
strain
prepar
differ
growth
stage
antibiot
mix
either
ad
ad
sampl
differ
set
experi
run
parallel
variabl
result
similar
outcom
bacteri
growth
agar
medium
plate
therefor
differ
proport
tween
lecithin
neutral
test
find
effect
concentr
optimum
combin
allow
success
bacteria
growth
final
set
experi
perform
prefer
tween
lecithin
proport
along
longer
neutral
time
plate
min
thorough
mix
mix
min
hand
vortex
prove
effect
give
good
disinfect
neutral
success
bacteria
growth
result
lowest
usabl
ratio
neutral
disinfect
